Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia

NCT00495079

Conditions
Acute Lymphoblastic Leukemia (ALL), Disease Attributes, Hematologic Diseases, +13 more
Locations
  • USC - Norris Cancer Center Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California Medical Center San Francisco, California, United States
  • Stanford Hospitals and Clinics Stanford, California, United States
View all 33 locations
View Trial Details
Completed

A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes

NCT01620242

Conditions
Disease Attributes, Head and Neck Neoplasms, Metastatic Head and Neck Cancer, +6 more
Locations
  • Centre Oscar Lambret Lille, France
  • Centre Léon Berard Lyon, France
  • Centre Antoine Lacassagne Nice, France
  • Institut Curie Paris, France
View Trial Details
Completed

A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

NCT01610206

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +21 more
Locations
  • Maine Medical Center (MMP Women's Health) Scarborough, Maine, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Duke University Durham, North Carolina, United States
  • Stephenson Cancer Center University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer

NCT01623349

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +22 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details
Completed

Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer

NCT02369874

Conditions
Disease Attributes, Head and Neck Neoplasms, Neoplasms, +5 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Fullerton, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Redondo Beach, California, United States
View all 168 locations
View Trial Details

Related conditions